# Fondazione Michelangelo

Source: https://onco.cc/institutions/fondazione-michelangelo/  
OnCo record `fondazione-michelangelo` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Milan research foundation, led by Luca Gianni, that designs and runs academic breast cancer trials such as NeoSphere and the neoadjuvant HER2 studies.

## Summary

The Fondazione Michelangelo is an independent, not-for-profit clinical research organisation in Milan founded to run investigator-led cancer trials, chiefly in breast cancer. Under its president Luca Gianni it has coordinated the NeoSphere, NOAH and neoadjuvant biomarker studies that helped establish pathological complete response as an endpoint for HER2-positive breast cancer, and it collaborates with the Fondazione IRCCS Istituto Nazionale dei Tumori and hospitals across Italy.

## Fields

- Kind: Institution
- Last checked: 2026-09-18
- Also known as: Michelangelo Foundation for the Advancement of the Study and Treatment of Cancer
- City: Milan, IT
- Type: research-institute

## Connected records

- cancers: [HER2-positive breast cancer](https://onco.cc/cancers/breast-her2-positive/)
- institutions: [Fondazione IRCCS Istituto Nazionale dei Tumori](https://onco.cc/institutions/int-milan/)
- people: [Luca Gianni](https://onco.cc/people/luca-gianni/)

---
JSON: https://onco.cc/api/v1/entities/fondazione-michelangelo.json